U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: April 14-20, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: April 14-20, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 04/15/2024
Location: Silver Spring, MD
Subject: Infant Formula
FDA Participant/Group: JAMES JONES; HILARY MARSTON; MARK RAZA; MICHAEL ROGERS;
Non FDA Participant/Group: Robert Ford (Abbott Laboratories);

Event Date: 04/18/2024
Location: Virtual
Subject: Medical Device Manufacturers Association 2024 Annual Meeting; Speaker: Fireside Chat
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, academia, media, and other stakeholders

Event Date: 04/19/2024
Location: Washington, DC
Subject: American College of Preventive Medicine PM2024 Conference; Presenter Plenary Session 2: National/Federal Leadership in Medicine and Public Health
FDA Participant/Group: DAYLE CRISTINZIO;
Non FDA Participant/Group: Academia, industry, government, and other invited attendees

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

Event Date: 04/18/2024
Location: Washington, DC
Subject: Senate Select Committee on Intelligence Biotechnology Roundtable
FDA Participant/Group: N/A
Non FDA Participant/Group: Casey Blackburn (Office of the Director of National Intelligence); Reta Jo Lewis (Export-Import Bank of the United States); Thea Kendler (U.S. Department of Commerce); Arati Prabhakar (Office of Science and Technology Policy); Anne Cheever (National Security Council, The White House); Nafisa Jiwani (U.S. International Development Finance Corporation); Julia Limage (Administration for Strategic Preparedness and Response / BARDA); Kate Sixt (U.S. Department of Defense); Senator Mark Warner (D-VA); Senator Todd Young (R-IN); Senator Marco Rubio (R-FL); Senator Alex Padilla (D-CA)

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 04/15/2024
Location: Washington, DC
Subject: North American Agricultural Journalists Annual Meeting; Speaker: FDA Foods Program Update
FDA Participant/Group: TARA RABIN;
Non FDA Participant/Group: Approximately 40 journalists from across the United States and Canada

Event Date: 04/18/2024
Location: College Park, MD
Subject: Food Traceability Rule Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several staff from the Food Industry Association and the International Foodservice Distributors Association

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 04/15/2024
Location: Washington, DC
Subject: White House Initiative on Women's Health Research (WHIWHR) Interagency Meeting on Research and Data Standards
FDA Participant/Group: N/A
Non FDA Participant/Group: Tamara Allard (The White House Initiative);

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 04/15/2024
Location: Virtual
Subject: Neurology Drug Program
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members of the American Brain Coalition (ABC)

Event Date: 04/18/2024
Location: Silver Spring, MD
Subject: Eli Lilly's Drug Manufacturing Network
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of Eli Lilly

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 04/15/2024
Location: Virtual
Subject: Economist Impact 2nd Annual Cell and Gene Therapy Summit; Keynote Interview
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry and healthcare stakeholders

Event Date: 04/16/2024
Location: Bethesda, MD
Subject: Lupus Accelerating Breakthroughs Consortium Annual Meeting; Keynote Presentation: Advancing Cell and Gene Therapies for Autoimmune Diseases
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, scientific, government, and patient stakeholders

Event Date: 04/18/2024
Location: Virtual
Subject: Emory Winship Cancer Institute Fellow Career Panel; Panelist
FDA Participant/Group: N/A
Non FDA Participant/Group: Healthcare stakeholders

Event Date: 04/18/2024
Location: Virtual
Subject: Eye Bank Association of America / FDA Executive Liaison Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from the Eye Bank Association of America

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 04/18/2024
Location: Washington, DC
Subject: Medical Device Manufacturers Association Annual Meeting; Speaker: CDRH Town Hall
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, academia, and other stakeholders

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 04/15/2024
Location: St. Louis, MO
Subject: NatCon24 Conference; Keynote Address and Panel Discussion: Menthol and Health - Addressing Health Equity Through Tobacco Treatment
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of the National Council for Mental Wellbeing and other conference attendees

Event Date: 04/18/2024
Location: Washington, DC
Subject: 1st National Tobacco Endgame Summit; Keynote Address with Q&A: Importance of End Game - Cessation Care Package
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of Action on Smoking and Health (ASH) and other conference attendees

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

 
Back to Top